Experimental analysis explores thrombin's protection from heparin-antithrombin III and its inactivation by other inhibitors.
Reagents. Human a-thrombin, sp act 2,850 U/mg, was generously provided by Dr. J. Fenton II, New York State Department of
No takes yet. Share an insight, caveat, or question.
Weitz et al. (1990) studied this question.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: